<DOC>
	<DOCNO>NCT02443194</DOCNO>
	<brief_summary>Primary tumor glioblastoma common malignant brain . Standard treatment include biopsy excision tumor order obtain pathological diagnosis , tumor mass reduction . After surgery patient treat radiation Temodal . The common psychiatric symptom patient population depression , value approximately 50 % patient glioma . Depression adversely affect quality life patient also impair ability cognitive function due complex clinical course patient glioblastoma . There tendency give Diagnosis depression patient population , due lack awareness , knowledge literature subject . This study design prospectively randomize , control , double-blind study . This method recruitment - patient undergo resection biopsy glioblastoma ( newly diagnose glioblastoma ) , immediately diagnosis , patient receive explanation study sign consent form enter research .</brief_summary>
	<brief_title>The Effect Duloxetine Mood , Quality Life Cognitive Functioning Glioblastoma Patients</brief_title>
	<detailed_description>This study design prospectively randomize , control , double-blind study.This method recruitment patient undergo resection biopsy glioblastoma ( newly diagnose glioblastoma ) , immediately diagnosis , patient receive explanation study sign consent form enter research . Patients underwent resection biopsy glioblastoma ( newly diagnose glioblastoma ) , randomization ratio 1 : 1 pharmacist ( age , Karnofsky score , degree tumor resection ) two research group : Group # 1 : consist 50 patient treat immediately diagnosis , 30 mg Cymbalta morning week dose exceed 60 mg 3 month . Group # 2 : include 50 patient treat immediately diagnosis placebo 3 month .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Patients sign informed consent form Patients underwent resection biopsy GBM KPS &gt; 70 Patients treated antidepressant Unable answer questionnaire inability communicate Patients treat ; monoamine oxidase inhibitor ( MAOI ) CYP1A2 Inhibitors ( CYP2D6 inhibitor ( SSRIs fluoxetine , paroxetine , antiarrhythmia quinidine ) Patients Glaucoma , narrow angle Severe renal dysfunction . According laboratory criterion specify earlier . Hepatic insufficiency laboratory criterion mention earlier . Pregnant woman Patients Dementia Patients previously suffer depression past within 5 year diagnosis , currently receive drug therapy Sensitivity ingredient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>depression</keyword>
	<keyword>glioblastoma</keyword>
</DOC>